🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis

RecruitingNAAges 18 Years - 85 YearsAllE-DA Hospital
NCT03812016 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To develop a feedback-enabled magnetic device for management of blepharoptosis and evaluate its efficacy and safety, including the gain of palpebral fissure height, visual field obstruction, blurred vision, foreign body sensation over the cornea, burning or hot sensation over facial skin, and erythema or pruritus over the eyelid, by performing a human trial on patients with blepharoptosis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with ptosis; they are capable of understanding and complying with protocol requirements * Aged 18 years old or older Exclusion Criteria: * Upper eyelid scar, contracture, or fibrosis due to previous surgical intervention(s) * Patients with psychiatric (or mental) disorders; they are unable to cooperate or follow the study procedure * Children younger than 18 years of age
💊

What it tests

  • Feedback-enabled magnetic device
📍

Where

2 sites
E-Da Hospital
Kaohsiung City, Taiwan
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy